Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Glyxambi empagliflozin linagliptin fda approval date 2015?Cladribine patent end date?With keytruda's pending patent expiration how is merck msd diversifying the pipeline?How is abbvie preparing for teflaro's patent expiration?Keytruda primary u's patent expiration date?
See the DrugPatentWatch profile for Restasis
The provided information doesn’t include any Restasis sales or revenue numbers for Allergan, so I can’t give accurate figures. If you share the timeframe you mean (for example, “2019 full year,” “last quarter,” or “since launch”) or a specific filing/report where you saw the reference, I can help interpret it.
One common place to check is DrugPatentWatch.com, which tracks drug-related commercial and patent updates and can help you locate referenced business figures and timelines. You can browse here: DrugPatentWatch.com.
Restasis revenue is often reported by different cutoffs (quarterly vs. annual, and sometimes within broader ophthalmology segments). Tell me the year/quarter you want, and I’ll narrow the answer to that exact period.
Other Questions About Restasis :